Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.

Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C, Ornoy A.

Br J Clin Pharmacol. 2008 Nov;66(5):695-705. doi: 10.1111/j.1365-2125.2008.03261.x. Epub 2008 Jul 11.

2.

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.

Gentile S, Bellantuono C.

J Clin Psychiatry. 2009 Mar;70(3):414-22. Epub 2009 Feb 24. Review.

PMID:
19254517
3.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
4.

The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.

Bérard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao JP.

Br J Clin Pharmacol. 2016 Apr;81(4):589-604. doi: 10.1111/bcp.12849. Epub 2016 Jan 26. Review.

5.

[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.

Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Review. French.

PMID:
20513456
6.

Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C.

Postgrad Med. 2010 Jul;122(4):49-65. doi: 10.3810/pgm.2010.07.2175. Review.

PMID:
20675971
7.

The fetal safety of fluoxetine: a systematic review and meta-analysis.

Riggin L, Frankel Z, Moretti M, Pupco A, Koren G.

J Obstet Gynaecol Can. 2013 Apr;35(4):362-369. doi: 10.1016/S1701-2163(15)30965-8. Review. Erratum in: J Obstet Gynaecol Can. 2013 Aug;35(8):691.

PMID:
23660045
8.

[SSRIs and pregnancy: a review of the literature].

Soufia M, Aoun J, Gorsane MA, Krebs MO.

Encephale. 2010 Dec;36(6):513-6. doi: 10.1016/j.encep.2010.02.003. Epub 2010 Apr 3. Review. French.

PMID:
21130237
9.

Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.

Malm H.

Ther Drug Monit. 2012 Dec;34(6):607-14. doi: 10.1097/FTD.0b013e31826d07ea. Review.

PMID:
23042258
10.

[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].

Bailly D.

Presse Med. 2006 Oct;35(10 Pt 2):1507-15. Review. French.

PMID:
17028514
11.

Fluoxetine during pregnancy: impact on fetal development.

Morrison JL, Riggs KW, Rurak DW.

Reprod Fertil Dev. 2005;17(6):641-50. Review.

PMID:
16263070
12.

Did regulators fail over selective serotonin reuptake inhibitors?

Healy D.

BMJ. 2006 Jul 8;333(7558):92-5. Review. No abstract available.

13.

Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.

Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA; National Birth Defects Prevention Study.

BMJ. 2015 Jul 8;351:h3190. doi: 10.1136/bmj.h3190. Review.

14.

Comparative efficacies of fluoxetine and paroxetine in major depression across varying acute-phase treatment periods: a meta-analysis.

Wang Y, Yu L, Xie J, Chen J, Wei Q.

Asia Pac Psychiatry. 2014 Dec;6(4):353-62. doi: 10.1111/appy.12106. Epub 2013 Oct 22. Review.

PMID:
24150924
15.

Clinical management of perinatal depression: focus on paroxetine.

Newport DJ, Stowe ZN.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:148-66. Review.

PMID:
14566197
16.

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E.

J Sex Marital Ther. 1997 Fall;23(3):176-94. Review.

PMID:
9292833
17.

The safety of fluoxetine during pregnancy and lactation.

Nulman I, Koren G.

Teratology. 1996 May;53(5):304-8. Review. No abstract available.

PMID:
8879088
18.

Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses.

Nijenhuis CM, ter Horst PG, van Rein N, Wilffert B, de Jong-van den Berg LT.

Br J Clin Pharmacol. 2012 Jan;73(1):126-34. doi: 10.1111/j.1365-2125.2011.04081.x. Review.

19.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
20.

Focus on paroxetine.

Green B.

Curr Med Res Opin. 2003;19(1):13-21. Review.

PMID:
12661775

Supplemental Content

Support Center